6NCG
Crystal Structure of Human Vaccinia-related kinase 2 (VRK-2) bound to pyridin-benzenesulfonamide inhibitor
Summary for 6NCG
Entry DOI | 10.2210/pdb6ncg/pdb |
Descriptor | Serine/threonine-protein kinase VRK2, 4-[6-amino-5-(3,5-difluoro-4-hydroxyphenyl)pyridin-3-yl]benzene-1-sulfonamide, SULFATE ION, ... (4 entities in total) |
Functional Keywords | transferase, protein kinase domain, structural genomics, structural genomics consortium, sgc, transferase-transferase inhibitor complex |
Biological source | Homo sapiens (Human) |
Total number of polymer chains | 2 |
Total formula weight | 74427.25 |
Authors | dos Reis, C.V.,Chiodi, C.G.,de Souza, G.P.,Guimaraes, C.,Mascarello, A.,Gama, F.,Ferreira, M.,Counago, R.M.,Massirer, K.B.,Elkins, J.M.,Arruda, P.,Edwards, A.M.,Structural Genomics Consortium (SGC) (deposition date: 2018-12-11, release date: 2019-01-16, Last modification date: 2023-10-11) |
Primary citation | dos Reis, C.V.,Chiodi, C.G.,de Souza, G.P.,Azevedo, H.,Guimaraes, C.,Mascarello, A.,Gama, F.,Ferreira, M.,Counago, R.M.,Massirer, K.B.,Arruda, P.,Elkins, J.M.,Edwards, A.M.,Structural Genomics Consortium (SGC) Crystal Structure of Human Vaccinia-related kinase 2 (VRK-2) bound to pyridin-benzenesulfonamide inhibitor To Be Published, |
Experimental method | X-RAY DIFFRACTION (2.45 Å) |
Structure validation
Download full validation report